MEDMEN ENTERPRISES WKN: A2JM6N ISIN: CA58507M1077 Kürzel: MMNFF Forum: Aktien Thema: Hauptdiskussion

Aus dem SH Forum: I reached out to Medmen with a question re: latest rumours. Here is the response. Although it didn’t address the concern it seems to stand by it’s prior commitments to reshape the company. TIme will tell but I’m not convinced yet they’re history. Jmo. Thank you for being a MedMen shareholder and reaching out to us. We understand and share your frustration, MedMen continues to focus on stabilizing and executing on our growth plans. As we mentioned on our previous earnings call, we have spent a significant amount of time evaluating our long-term strategy and how to best position MedMen for profitability while also maintaining growth. We have set five specific goals for the Company, which include: 1) focusing on our core markets, while simultaneously divesting any non-core assets; 2) reducing our corporate SG&A; 3) driving asset-level EBITDA at both our retail stores and factories; 4) limiting our cash outlays over the next 12 months; and 5) reinvesting in both our employees and our culture. We will re-assess our strategy each quarter. I would encourage you to tune into our next earnings call for further colour on our progress. If you have not done so already, you can sign up to receive alerts on any press releases and/or to receive monthly key highlights at the bottom of the investor section of our website to stay up to speed with the latest news on MedMen. Of course – please don’t hesitate to reach out with any additional questions. Kind regards, MedMen Customer Experience

Ich selber denke auch, dass grizzle da merkwürdige Ziele verfolgt. Die selbe headline gab's vor ner Woche oder so bei Aurora. Deshalb auch mein Text mit dem "fett weg bekommt"

Vorsicht! Man kann, aber muss nicht immer alles glauben. Auch wenn ich nicht mehr hier drin bin.

Der nächste der sein Fett weg bekommt

https://grizzle.com/medmen-effectively-bankrupt/

https://s27415.pcdn.co/wp-content/uploads/ommu_updates/2020/011720-OMMU-Update.pdf

MedMen to Announce Second Quarter Fiscal 2020 Financial Results on February 26, 2020 $MMEN #PotStocks https://t.co/0y6TNrKZk6 https://t.co/OaferNxVlq

https://www.businesswire.com/news/home/20200110005572/en/

Auf den Artikel bezogen? Für mich ein logischer Schritt

Wie meinst, 420?

Was haltet ihr davon?

https://www.businesswire.com/news/home/20191227005073/en/

MedMen: Price Targets and Ratings after Q1 Earnings Schon etwas älter 4.12 aber interessant Following MedMen’s weak first-quarter performance, Canaccord Genuity cut its price target by 50% to 1 Canadian dollar. As reported by Cantech Letter, Nav Malik of Industrial Alliance Securities lowered his price target from $1.65 to $0.85......The new consensus price target represents a 12-month return potential of 330.7%. Keine Ahnung ob die Analysten da recht haben 🤷‍♂️. Zu den 0.85$ (0.76€) ist nich ein bisschen Luft. https://www.google.com/amp/s/marketrealist.com/2019/12/medmen-price-targets-and-ratings-after-q1-earnings/%3famp Interessant auch der Schluss Let’s look at analysts’ recommendations for MedMen’ peers: Zu CURA und CL hab ich was ins Forum gestellt. Keine Empfehlung nur zur Info.

Jiippiie

Auch CSE